NYSE US 100
17.998,79
PKT
+19,46
PKT
+0,11
%
Werbung
Analysen zu NYSE US 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.04.07 | Eli Lilly hold | Deutsche Securities | |
18.04.07 | Johnson Johnson buy | Hillard Lyons | |
17.04.07 | Coca-Cola buy | Stifel Nicolaus & Co. | |
17.04.07 | Medtronic outperform | Sanford C. Bernstein & Co | |
17.04.07 | Wells Fargo overweight | Lehman Brothers | |
17.04.07 | Citigroup buy | Punk, Ziegel & Co | |
17.04.07 | Citigroup akkumulieren | Independent Research | |
17.04.07 | Citigroup buy | SEB | |
17.04.07 | Eli Lilly reduce | Jyske Bank | |
18.04.07 | Eli Lilly overweight | Prudential Financial | |
17.04.07 | Corning neutral | UBS | |
16.04.07 | Fannie Mae (Federal National Mortgage Association) buy | Banc of America Sec. | |
16.04.07 | AT&T outperform | RBC Capital Markets | |
16.04.07 | Valero Energy hold | Citigroup | |
17.04.07 | Pfizer accumulate | Jyske Bank | |
17.04.07 | Corning neutral | UBS | |
16.04.07 | Merck strong buy | Raymond James | |
16.04.07 | Merck outperform | Bear Stearns | |
13.04.07 | Merck buy | Deutsche Securities | |
13.04.07 | Merck neutral | JP Morgan | |
13.04.07 | Merck neutral | Goldman Sachs | |
13.04.07 | Johnson Johnson | DZ-Bank | |
13.04.07 | Citigroup akkumulieren | Independent Research | |
13.04.07 | Merck buy | Citigroup | |
13.04.07 | Boeing kaufen | Fuchsbriefe | |
17.04.07 | Bayer kaufen | Weberbank | |
16.04.07 | Eli Lilly reduce | Jyske Bank | |
13.04.07 | Boeing | Der Aktionärsbrief | |
16.04.07 | Merck neutral | UBS | |
13.04.07 | HP above average | Caris & Company | |
12.04.07 | Alcoa halten | Frankfurter Tagesdienst | |
12.04.07 | Citigroup buy | Deutsche Securities | |
12.04.07 | PepsiCo outperform | Sanford C. Bernstein & Co | |
12.04.07 | Halliburton outperform | Evern Securities | |
12.04.07 | Citigroup overweight | Lehman Brothers | |
12.04.07 | Eli Lilly reduce | Jyske Bank | |
12.04.07 | IBM akkumulieren | Independent Research | |
12.04.07 | Citigroup buy | SEB | |
12.04.07 | Alcoa sell | Goldman Sachs | |
12.04.07 | Merck strong buy | Raymond James |